Severe Hypoglycaemia Leading to Hospital Admission in Type 2 Diabetic Patients Aged 80 Years or Older

被引:56
作者
Greco, D. [1 ]
Pisciotta, M. [1 ]
Gambina, F. [1 ]
Maggio, F. [1 ]
机构
[1] S Biagio Hosp, Div Diabetol, Marsala, TP, Italy
关键词
severe hypoglycaemia; type; 2; diabetes; elderly; risk factors; long-acting sulphonylurea; dementia; INSULIN THERAPY; MELLITUS; RISK; SULFONYLUREAS; GLIBENCLAMIDE; REPAGLINIDE; KNOWLEDGE; SYMPTOMS; DEMENTIA; ANALOGS;
D O I
10.1055/s-0029-1241823
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Evidence is mounting that hypoglycaemia among elderly diabetic patients is a very real and costly concern. Objective of this study was to determine the incidence and risk factors for developing severe hypoglycaemia leading to hospital admission, among type 2 diabetic subjects aged 80 years or older. Hypoglycaemia was defined as a symptomatic event requiring treatment with i.v. glucose and confirmed by a blood glucose determination <50mg/dl. During a eight-year period severe hypoglycaemia was identified in 99 subjects. These patients were found to have a reduced cognitive ability, a heavy burden of comorbid disease and a HbA1c values of 5.9%. Of the hypoglycaemic episodes, 76 occurred in patients taking glibenclamide. Diabetes therapy was prescribed by general practitioners in 85 of them. Only 26 patients performed regular home blood glucose self-monitoring. Severe hypoglycaemia is a serious and not uncommon metabolic emergency among patients with type 2 diabetes aged 80 years or older; it is more frequent in patients with considerable comorbidity undergoing aggressive diabetes management and in users of a long-acting sulphonylurea. In elderly subject, each patient's risk for hypoglycaemia should be considered and therapy should be individualized accordingly; in our opinion, a great number of episodes may be avoided by teaching the principles of blood glucose monitoring and involving general practitioners in outpatients management of diabetes mellitus.
引用
收藏
页码:215 / 219
页数:5
相关论文
共 32 条
[1]
ALLICAR M, 2000, PRESSE MED, V29, P837
[2]
Hypoglycaemia in Type 2 diabetes [J].
Amiel, S. A. ;
Dixon, T. ;
Mann, R. ;
Jameson, K. .
DIABETIC MEDICINE, 2008, 25 (03) :245-254
[3]
ASPLUND K, 1983, DIABETOLOGIA, V24, P412
[4]
The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes [J].
Baxter, Mike A. .
ACTA DIABETOLOGICA, 2008, 45 (04) :253-268
[5]
Drug-induced hypoglycemic coma in 102 diabetic patients [J].
Ben-Ami, H ;
Nagachandran, P ;
Mendelson, A ;
Edoute, Y .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) :281-284
[6]
Risk of dementia in diabetes mellitus: a systematic review [J].
Biessels, GJ ;
Staekenborg, S ;
Brunner, E ;
Brayne, C ;
Scheltens, P .
LANCET NEUROLOGY, 2006, 5 (01) :64-74
[7]
Chau Diane, 2001, Clinical Diabetes, V19, P172, DOI 10.2337/diaclin.19.4.172
[8]
Hypoglycaemia in elderly patients with diabetes mellitus - Causes and strategies for prevention [J].
Chelliah, A ;
Burge, MR .
DRUGS & AGING, 2004, 21 (08) :511-530
[9]
PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[10]
Repaglinide - A review of its therapeutic use in type 2 diabetes mellitus [J].
Culy, CR ;
Jarvis, B .
DRUGS, 2001, 61 (11) :1625-1660